ArticleInternal medicine (Tokyo, Japan)2018

The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.

Seigo Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.